Yervoy

NEW YORK (AP) - Drug maker Bristol-Myers Squibb Co. said Thursday the European Commission has approved its treatment Yervoy for use in adults with previously treated advanced melanoma, the deadliest type of skin cancer.

The New York drug maker said it will work to expedite Yervoy's availability across the European Union.

U.S. regulators approved Yervoy in March for advanced melanoma in both newly diagnosed patients and those who have failed on another therapy. The drug works by stimulating the immune system to recognize and then destroy cancer cells.